Clinical Trial Update: Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of BIA 9-1067 in idiopathic Parkinson's disease patients with wearing-off; results were posted in 2015…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIA 9-1067

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-01-08